Bruno Daniele

Summary

Affiliation: G. Rummo Hospital
Country: Italy

Publications

  1. ncbi Staging for liver cancer
    Bruno Daniele
    Medical Oncology Unit, G Rummo Hospital, Benevento, Italy
    Clin Liver Dis 9:213-23, vi. 2005
  2. ncbi Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma
    Ciro Gallo
    Department of Medicine and Public Health, Second University, Naples, Italy
    BMC Cancer 6:196. 2006
  3. ncbi Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma
    Bruno Daniele
    Medical Oncology Unit, G Rummo Hospital, Via dell Angelo 1, 82100 Benevento, Italy
    Gastroenterology 127:S108-12. 2004
  4. ncbi A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation
    Massimo Pancione
    Department of Biological and Environmental Sciences, University of Sannio, 82100 Benevento, Italy
    Hum Pathol 42:1047-52. 2011
  5. ncbi Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer
    Massimo Pancione
    Department of Biological and Environmental Sciences, University of Sannio, 82100 Benevento, Italy
    Hum Pathol 41:867-76. 2010
  6. ncbi Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinoma
    Bruno Daniele
    Oncology Unit, G Rummo Hospital, Benevento, Italy
    Hepatol Res 37:S206-9. 2007
  7. ncbi Re: Design and endpoints of clinical trials in hepatocellular carcinoma
    Massimo Di Maio
    J Natl Cancer Inst 100:1557; author reply 1557-8. 2008
  8. ncbi [Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography]
    Emiddio Barletta
    Recenti Prog Med 96:295-9; quiz 328. 2005
  9. ncbi Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients
    Steven A Curley
    Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4095, USA
    Ann Surg 239:450-8. 2004
  10. ncbi Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients
    Alessandro Ottaiano
    Department of Clinical Immunology, National Cancer Institute, G Pascale Foundation, Naples, Italy
    Clin Cancer Res 12:2795-803. 2006

Collaborators

  • Francesco Perrone
  • Ciro Gallo
  • Francesco Izzo
  • Paolo Vallone
  • S A Curley
  • Yehuda Z Patt
  • Masao Omata
  • Fabio Farinati
  • R Mazzanti
  • Lee Ellis
  • Massimo Di Maio
  • Massimo Pancione
  • Sandro Pignata
  • Ermelinda De Maio
  • Emiddio Barletta
  • Arturo Di Blasi
  • Alessandra Fucci
  • Vittorio Colantuoni
  • Lina Sabatino
  • Alessandro Ottaiano
  • Rosario Vincenzo Iaffaioli
  • Paolo Delrio
  • Courtney L Scaife
  • Gabriella Aquino
  • Natalia Palombi
  • Anna Maria Dalena
  • Nicola Normanno
  • Pietro Carotenuto
  • Antonio Febbraro
  • Nicola Forte
  • Domenico Parente
  • Maria Carmela Piccirillo
  • Alessandro Morabito
  • Maria-Carmela Piccirillo
  • Maria Napolitano
  • Giampiero Marone
  • Luigi Elio Adinolfi
  • Carlo Del Naja
  • Guglielmo Nasti
  • Fabiana Castiglione
  • Caterina Ierano
  • Gerardo Botti
  • Maria Stanzione
  • Rosa Calemma
  • Gaetano Facchini
  • Silvana Elba
  • Giovanni Battista Gaeta
  • Ilario de Sio
  • Giuseppe Signoriello
  • Martina Felder
  • Antonio Giorgio
  • Enrico Leonardi
  • Annarita Aiello Talamanca
  • Valentina De Angelis
  • Vittorio Albino
  • Giuseppe Castello
  • Marzia Falanga
  • Vincenzo Boccia
  • Fabiana Tatangelo
  • Giuseppina Liguori
  • Oreste Cuomo
  • Valerio Parisi
  • Stefania Scala
  • Gaetano Capuano
  • Renato Franco
  • Maurizio Capuozzo
  • Vincenza Tinessa
  • Bruno D Fornage
  • Judy L Chase
  • Franco Cremona
  • Richard D Lozano
  • Francesco Fiore
  • Jean Nicolas Vauthey
  • Karen B Gonzalez
  • Misty L Woodall
  • Paolo Marra
  • Jeffrey E Gershenwald

Detail Information

Publications17

  1. ncbi Staging for liver cancer
    Bruno Daniele
    Medical Oncology Unit, G Rummo Hospital, Benevento, Italy
    Clin Liver Dis 9:213-23, vi. 2005
    ..The peculiarity of hepatocellular carcinoma patients are addressed, and each individual prognostic systems for hepatocellular carcinoma is presented and discussed...
  2. ncbi Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma
    Ciro Gallo
    Department of Medicine and Public Health, Second University, Naples, Italy
    BMC Cancer 6:196. 2006
    ..However, a recent report suggested that the drug might prolong survival among patients with well preserved liver function. The aim of this paper is to validate this hypothesis...
  3. ncbi Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma
    Bruno Daniele
    Medical Oncology Unit, G Rummo Hospital, Via dell Angelo 1, 82100 Benevento, Italy
    Gastroenterology 127:S108-12. 2004
    ..US seems more efficient as a screening tool. Pathology assessment of liver explants in living-donor transplantation programs will provide more precise and reliable information regarding the value of AFP and US as HCC screening tools...
  4. ncbi A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation
    Massimo Pancione
    Department of Biological and Environmental Sciences, University of Sannio, 82100 Benevento, Italy
    Hum Pathol 42:1047-52. 2011
    ..This is the first case of a colorectal carcinoma with rhabdoid features, "CpG island methylator phenotype," high microsatellite instability associated with a BRAF mutation, and patient poorer outcome...
  5. ncbi Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer
    Massimo Pancione
    Department of Biological and Environmental Sciences, University of Sannio, 82100 Benevento, Italy
    Hum Pathol 41:867-76. 2010
    ..We suggest that a combination of low beta-catenin and high p53 expression in primary colorectal cancers may be a prognostic factor in predicting the progression of the disease, the occurrence of metastasis, and a more severe outcome...
  6. ncbi Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinoma
    Bruno Daniele
    Oncology Unit, G Rummo Hospital, Benevento, Italy
    Hepatol Res 37:S206-9. 2007
    ..Conclusions: The CLIP score keeps good prognostic and discriminative abilities after a longer follow up and remains one the most useful prognostic system for hepatocellular carcinoma...
  7. ncbi Re: Design and endpoints of clinical trials in hepatocellular carcinoma
    Massimo Di Maio
    J Natl Cancer Inst 100:1557; author reply 1557-8. 2008
  8. ncbi [Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography]
    Emiddio Barletta
    Recenti Prog Med 96:295-9; quiz 328. 2005
    ..Pathology assessment of liver explants in living donor transplantation programs will provide more precise and reliable information regarding the value of AFP and ultrasonography as HCC screening tools...
  9. ncbi Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients
    Steven A Curley
    Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4095, USA
    Ann Surg 239:450-8. 2004
    ..We performed this prospective analysis to determine early (within 30 days) and late (more than 30 days after) complication rates associated with hepatic tumor RFA...
  10. ncbi Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients
    Alessandro Ottaiano
    Department of Clinical Immunology, National Cancer Institute, G Pascale Foundation, Naples, Italy
    Clin Cancer Res 12:2795-803. 2006
    ....
  11. ncbi Transcatheter arterial procedures in the treatment of patients with hepatocellular carcinoma: a review of literature
    Ermelinda De Maio
    Medical Oncology B, National Cancer Institute of Naples, Via M. Semmola, 80131, Naples, Italy
    Crit Rev Oncol Hematol 46:285-95. 2003
    ..Thus, there is an urgent need for prospective controlled trials in order assess the impact of TAP on survival and to compare different procedures...
  12. ncbi Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP)
    Sandro Pignata
    Oncologia Medica B, Istituto Nazionale per lo Studio e la Cura dei Tumori, Napoli, Italy
    Crit Rev Oncol Hematol 59:243-9. 2006
    ..CONCLUSION: Elderly patients with HCC have a worse prognosis compared to non-elderly ones. Such difference seems the consequence of undertreatment...
  13. ncbi Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer
    Courtney L Scaife
    Departments of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Surg Oncol 10:348-54. 2003
    ..The high rate of disease recurrence in our patients indicates that novel combinations of regional and systemic therapies are needed to improve patient outcomes...
  14. ncbi Is human hepatocellular carcinoma a hormone-responsive tumor?
    Massimo Di Maio
    Medical Oncology, N Giannettasio Hospital, Rossano 87068, Italy
    World J Gastroenterol 14:1682-9. 2008
    ..Negative results have been obtained also with anti-androgen therapy. In conclusion, there is no robust evidence to consider HCC a hormone-responsive tumor. Hormonal treatments should not be part of the current management of HCC...
  15. ncbi Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a Cancer of the Liver Italian Program (CLIP 08) retrospective case-control study
    Bruno Daniele
    Oncologia Medica B, Oncologia Chirurgica CM, Istituto Nazionale Tumori, Napoli, Italy
    J Clin Gastroenterol 36:63-7. 2003
    ..CONCLUSIONS: Patients with small HCC treated with hepatic resection or PEI have similar survival rates. In view of the higher cost and morbidity of hepatic resection, a prospective randomized study is warranted...
  16. ncbi Hepatocellular carcinoma: systemic treatments
    Massimo Di Maio
    Medical Oncology, National Cancer Institute, Naples, Italy
    J Clin Gastroenterol 35:S109-14. 2002
    ..In the future, innovative and promising therapeutic strategies will be tested in HCC, including new biologic target-based drugs, cyclooxygenase inhibitors, and gene therapy...
  17. ncbi Clinical features, etiology, and survival of hepatocellular carcinoma among different countries
    Masao Omata
    Department of Gastroenterology, University of Tokyo Graduate School of Medicine, Japan
    J Gastroenterol Hepatol 17:S40-9. 2002